Table 2.
Characteristics of cultures positive for bacterial infection taken in pre-COVID-19 and post-COVID-19 period.
| Total Positive Cultures N = 83 |
Pre-COVID-19 N = 36 |
Post-COVID-19 N = 47 |
p | |
|---|---|---|---|---|
| Type of culture (N, %) | ||||
| Urinoculture | 62 (74.7) | 31 (86.1) | 31 (66.0) | 0.036 |
| Urinoculture with MDR | 33 (53.2) | 16 (51.6) | 17 (54.8) | 0.799 |
| Bloodstream culture | 21 (25.3) | 5 (13.9) | 16 (34.0) | 0.036 |
| Bloodstream with MDR | 13 (61.9) | 2 (40.0) | 11 (68.8) | 0.038 |
| MDR infections (N, %) | 46 (55.4) | 18 (50.0) | 28 (59.6) | 0.384 |
| MDR bacteria (N, %) | 0.956 | |||
| E. coli | 32 (38.6) | 13 (36.1) | 19 (40.4) | 0.689 |
| MDR | 24 (75) | 9 (69.2) | 15 (78.9) | 0.105 |
| Klebsiella spp. | 15 (18.1) | 8 (22.2) | 7 (14.9) | 0.390 |
| MDR | 7 (46.6) | 4 (50.0) | 3 (42.8) | 0.289 |
| Enterococcus spp. | 14 (16.9) | 8 (22.2) | 6 (12.8) | 0.254 |
| MDR | 4 (28.6) | 2 (25) | 2 (33.3) | 0.401 |
| Proteus spp. | 3 (3.6) | 1 (2.8) | 2 (4.2) | 0.721 |
| MDR | 2 (66.7) | 1 (100) | 1 (50) | 0.747 |
| Pseudomonas spp. | 7 (8.4) | 3 (8.3) | 4 (8.5) | 0.977 |
| MDR | 3 (42.8) | 1 (33.3) | 2 (50) | 0.831 |
| Others | 2 (2.4) | 0 (0) | 2 (4.2) | 0.210 |
| MDR | 0 (0) | 0 (0) | 0 (0) | - |
| Enterobacter spp. | 3 (3.6) | 2 (5.6) | 1 (2.1) | 0.407 |
| MDR | 1 (33.3) | 1 (50) | 0 (0) | 0.207 |
| Staphylococcus spp. | 7 (8.4) | 1 (2.8) | 6 (12.8) | 0.132 |
| MDR | 5 (71.4) | 0 (0) | 5 (83.3) | 0.058 |
| MRSA | 1 (1.2) | 0 (0) | 1 (2.1) | 0.482 |
| ESBL | 33 (39.8) | 15 (41.7) | 18 (38.3) | 0.705 |
| CPB | 9 (10.8) | 3 (8.3) | 6 (12.8) | 0.725 |
MDR: multidrug-resistant bacteria. MRSA: Methicillin-resistant Staphylococcus aureus. ESBL: extended spectrum beta-lactamase producing bacteria. CPB: carbapenemase-producing bacteria.